(Q40042881)

16 September 2017

title

A comparison of the phenotypic susceptibility profiles of emtricitabine and lamivudine (English)

1 reference

16 September 2017

1 reference

Katyna Borroto-Esoda

1

1 reference

16 September 2017

Neil Parkin

series ordinal

2

1 reference

16 September 2017

Michael D Miller

series ordinal

3

1 reference

16 September 2017

publication date

1 January 2007

1 reference

Antiviral Chemistry & Chemotherapy

16 September 2017

published in

1 reference

16 September 2017

volume

18

1 reference

16 September 2017

issue

5

1 reference

16 September 2017

page(s)

297-300

1 reference

A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV.

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800505

Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800505

The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800505

Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800505

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800505

Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800505

Assessment of the relative potency of emtricitabine and lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800505

Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800505

10.1177/095632020701800505

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference